GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Destiny Pharma PLC (LSE:DEST) » Definitions » Cyclically Adjusted PB Ratio

Destiny Pharma (LSE:DEST) Cyclically Adjusted PB Ratio : 0.65 (As of Jun. 12, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Destiny Pharma Cyclically Adjusted PB Ratio?

As of today (2024-06-12), Destiny Pharma's current share price is £0.1175. Destiny Pharma's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 was £0.18. Destiny Pharma's Cyclically Adjusted PB Ratio for today is 0.65.

The historical rank and industry rank for Destiny Pharma's Cyclically Adjusted PB Ratio or its related term are showing as below:

LSE:DEST' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.93
Current: 0.89

During the past 10 years, Destiny Pharma's highest Cyclically Adjusted PB Ratio was 0.93. The lowest was 0.00. And the median was 0.00.

LSE:DEST's Cyclically Adjusted PB Ratio is ranked better than
65.2% of 661 companies
in the Biotechnology industry
Industry Median: 1.67 vs LSE:DEST: 0.89

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Destiny Pharma's adjusted book value per share data of for the fiscal year that ended in Dec23 was £0.096. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is £0.18 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Destiny Pharma Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Destiny Pharma's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Destiny Pharma Cyclically Adjusted PB Ratio Chart

Destiny Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 3.96

Destiny Pharma Semi-Annual Data
Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 3.96

Competitive Comparison of Destiny Pharma's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Destiny Pharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Destiny Pharma's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Destiny Pharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Destiny Pharma's Cyclically Adjusted PB Ratio falls into.



Destiny Pharma Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Destiny Pharma's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.1175/0.18
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Destiny Pharma's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Destiny Pharma's adjusted Book Value per Share data for the fiscal year that ended in Dec23 was:

Adj_Book=Book Value per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=0.096/130.5000*130.5000
=0.096

Current CPI (Dec23) = 130.5000.

Destiny Pharma Annual Data

Book Value per Share CPI Adj_Book
201412 0.047 99.900 0.061
201512 0.030 100.400 0.039
201612 0.037 102.200 0.047
201712 0.381 105.000 0.474
201812 0.280 107.100 0.341
201912 0.176 108.500 0.212
202012 0.208 109.400 0.248
202112 0.125 114.700 0.142
202212 0.104 125.300 0.108
202312 0.096 130.500 0.096

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Destiny Pharma  (LSE:DEST) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Destiny Pharma Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Destiny Pharma's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Destiny Pharma (LSE:DEST) Business Description

Traded in Other Exchanges
Address
Unit 36, Sussex Innovation Centre, Science Park Square, Falmer, Brighton, GBR, BN1 9SB
Destiny Pharma PLC is a clinical-stage biotechnology company which is focused on the development of medicines for the treatment of infectious disease. It is developing drugs for the prevention and treatment of infections caused by Antibiotic-Resistant (AR) bacteria. It is involved in developing XF-73 Dermal for the treatment of skin infections of antibiotic-resistant bacteria, XF-73 Nasal for prevention of post-surgical staphylococcal infection, XF Throat for prevention of staphylococcal hospital/ventilator-associated pneumonia infection.

Destiny Pharma (LSE:DEST) Headlines

No Headlines